Increasing Healthcare Industry Investment Propelling Gene Therapy Market Growth Is Supporting Development Across The Gene Therapy Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Gene Therapy Market In 2026 And 2030?

The gene therapy market has witnessed substantial growth in recent years. Its valuation is expected to rise from $16.36 billion in 2025 to $21.46 billion in 2026, indicating a compound annual growth rate (CAGR) of 31.2%. Historically, this expansion has been driven by the increasing incidence of genetic disorders, advancements in viral vector technology, rising research and development investments in gene therapy, supportive government policies, and greater awareness of rare diseases.

The gene therapy market is projected to experience substantial expansion over the upcoming years. Its valuation is anticipated to reach $35.61 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.5%. This projected increase during the forecast period is fueled by several factors, including the wider adoption of personalized medicine, the development of CRISPR and other gene editing treatments, a rise in both private and public investment, the incorporation of AI into gene therapy research, and an increase in international collaborative clinical trials. Key developments expected during this timeframe encompass the advancement of personalized gene therapies, the integration of CRISPR and gene editing techniques, the broadening of regulatory and ethical guidelines, innovations in advanced viral and non-viral vectors, and expanded collaborative research and clinical studies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Which Core Factors Are Supporting The Expansion Of The Gene Therapy Market?

Increased financial commitments in the healthcare industry are projected to boost the expansion of the gene therapy market in the foreseeable future. This involves dedicating capital to entities that offer medical services, produce medical equipment or pharmaceuticals, provide medical insurance, or otherwise contribute to the healthcare sector. Such investments are vital for the gene therapy industry, as numerous pharmaceutical firms are allocating resources to strengthen their patent portfolios and secure profitable partnerships. Strategic funding also supports the creation of innovative and advanced gene therapy products. For example, in April 2025, a report from the American Medical Association, a US-based professional organization, indicated that U.S. health spending in 2023 escalated by 7.5% to $4.9 trillion, or $14,570 per capita, exceeding the 4.6% rise observed in 2022. Thus, the growing investment in the healthcare industry is propelling the growth of the gene therapy market.

How Is The Gene Therapy Market Examined Through Segment Analysis?

The gene therapy market covered in this report is segmented –

1) By Gene Therapy Type: Germline Therapy, Somatic Cell Therapy

2) By Vector: Viral Vector, Non-Viral Vector

3) By Application: Oncology, Orphan Disease, Knee Osteoarthritis, Neurological Disorders

4) By End Users: Biopharmaceutical Companies, Research Institutes, Other End Users

Subsegments:

1) By Germline Therapy: Inherited Disease Treatment, Genetic Modification Of Embryos, Gene Editing Techniques, Ethical And Regulatory Considerations

2) By Somatic Cell Therapy: Cancer Gene Therapy, Monogenic Disorder Treatment, Gene Replacement Therapy, RNA-Based Therapies, Gene Editing Techniques

Which Trends Are Influencing The Expansion Of The Gene Therapy Market?

Major companies within the gene therapy market are concentrating on the development of advanced products, such as adeno-associated virus (AAV) vectors, to improve the precision and effectiveness of gene delivery for the treatment of various genetic disorders. An adeno-associated virus (AAV) vector is a commonly utilized tool in gene therapy for introducing genetic material into cells. For instance, in April 2024, Pfizer Inc., a US-based global biopharmaceutical company, obtained approval from the Food and Drug Administration (FDA), a US-based federal agency tasked with protecting public health, for BEQVEZ (fidanacogene elaparvovec-dzkt). BEQVEZ (fidanacogene elaparvovec-dzkt) is a gene therapy intended for adults suffering from moderate to severe hemophilia B, which is a genetic bleeding disorder. This condition is characterized by a deficiency in clotting factor IX (FIX), potentially leading to excessive bleeding. The therapy uses an adeno-associated virus (AAV) vector to deliver a functional copy of the FIX gene directly into liver cells, thereby assisting in the natural production of this essential clotting factor.

Who Are The Companies Shaping The Gene Therapy Market Landscape?

Major companies operating in the gene therapy market are UniQure NV, REGENXBIO Inc., Bristol-Myers Squibb, BioMarin Pharmaceuticals Inc., Jazz Pharmaceuticals Inc., Biocon, EdiGene Inc, Takeda Pharmaceutical, Daiichi Sankyo Company, Mitsubishi Tanabe Pharma, Merck, Lonza, Pfizer, Cellular Biomedicine Group, GenScript, Albumedix Ltd, Catalent, Freeline Therapeutics, DiNAQOR AG, Vivet Therapeutics, Allergan, Amgen, Biocad, Celgene Corporation, Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Bayer AG, Juno Therapeutics, Allogene Therapeutics, Bluebird Bio, Regen BioPharma, Bellicum, BrainStorm Cell Therapeutics, Pluristem, Sanofi

Access The Complete Gene Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Which Region Is The Dominant Market In The Gene Therapy Market?

North America was the largest region in the gene therapy market in 2025. The regions covered in the gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Gene Therapy Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=3395&type=smp

Browse Through More Reports Similar to the Global Gene Therapy Market 2026, By The Business Research Company

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Gene Editing Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795